Back to Companies
Nurix Therapeutics, Inc.
NRIXNasdaqCIK: 0001549595
Over the 44 most recent insider filings, Nurix Therapeutics, Inc. (NRIX) has seen activity from 12 distinct insiders — all of them on the sell side. The activity is heavily weighted toward selling: $0 bought versus $3.6M sold, net sales of $3.6M. SANDS ARTHUR T (President, CEO, Director) is the most active by dollar volume, and the single largest transaction was $9.3M by SANDS ARTHUR T. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$23.0M
Purchases
$0
Sales
$3.6M
Unique Insiders
12
Recent Insider Trades
44 loaded
| Jul 30 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $90.0K |
| Jul 30 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $90.0K |
| Jul 30 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $66.5K |
| Jul 2 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $259.4K |
| Jun 25 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $107.9K |
| Jun 25 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $580.5K |
| Jun 2 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $135.3K |
| May 15 | NRIX Nurix Therapeutics, Inc. | Reinsdorf Judith A | Director | Award | $495.6K |
| May 15 | NRIX Nurix Therapeutics, Inc. | Baynes Roy D. | Director | Award | $495.6K |
| May 15 | NRIX Nurix Therapeutics, Inc. | DANSEY ROGER D | Director | Award | $495.6K |
| May 15 | NRIX Nurix Therapeutics, Inc. | Silva Paul M | Director | Award | $495.6K |
| May 15 | NRIX Nurix Therapeutics, Inc. | Kapur Anil | Director | Award | $495.6K |
| May 15 | NRIX Nurix Therapeutics, Inc. | Saltzman Edward C | Director | Award | $495.6K |
| May 15 | NRIX Nurix Therapeutics, Inc. | GREGORY JULIA P | Director | Award | $495.6K |
| May 15 | NRIX Nurix Therapeutics, Inc. | Lacey David L. | Director | Award | $495.6K |
| May 5 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $233.3K |
| May 4 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $138.2K |
| May 1 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $90.4K |
| Apr 30 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $53.5K |
| Apr 30 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $53.5K |
| Apr 30 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $39.7K |
| Apr 2 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $124.1K |
| Mar 2 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $125.8K |
| Feb 10 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Award | $1.5M |
| Feb 10 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Award | $1.5M |
| Feb 10 | NRIX Nurix Therapeutics, Inc. | SANDS ARTHUR T | President, CEO, Director | Award | $9.3M |
| Feb 10 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Award | $1.5M |
| Feb 9 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $237.6K |
| Feb 3 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Exercise | $52.6K |
| Jan 20 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $69.3K |
| Dec 18 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $67.3K |
| Nov 24 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $641.7K |
| Nov 10 | NRIX Nurix Therapeutics, Inc. | DANSEY ROGER D | Director | Award | $626.0K |
| Nov 10 | NRIX Nurix Therapeutics, Inc. | DANSEY ROGER D | Director | Other | $0 |
| Nov 3 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $78.9K |
| Oct 30 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $46.6K |
| Oct 30 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $40.1K |
| Oct 30 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $52.3K |
| Oct 23 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Award | $0 |
| Sep 17 | NRIX Nurix Therapeutics, Inc. | GREGORY JULIA P | Director | Exercise | $40.0K |
| Aug 1 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $59.6K |
| Jul 30 | NRIX Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | Sell | $46.1K |
| Jul 30 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | Sell | $51.7K |
| Jul 30 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $51.7K |
44 filings